Title / Affiliation
Corporate Vice President, Novo Nordisk A/S
Title of PDM2021 Presentation
Thoughts on Precision Medicine in Diabetes: an Industry Perspective.
Rasmus Rabøl has several years of experience in drug development within diabetes and obesity. During his ten years with Novo Nordisk he has held positions within clinical development and project management and is currently head of the area of Clinical Pharmacology and Translational Medicine. Prior to joining Novo Nordisk, Dr. Rabøl worked in internal medicine, and he earned his PhD in endocrinology from the University of Copenhagen while working part time for the Danish Medicines Agency.